Back to the future 3
A trio of trends that pharma needs to contend with in 2024
1st December 2023
Web Exclusives
Precision decision
What to consider when evaluating UK, US or EU for MedTech markets
24th November 2023
Future proofing
MHRA to recognise medicine approvals from trusted partner markets
21st November 2023
Shape shifters
Transitioning from a linear to circular approach in sustainability
13th November 2023
Long and winding road
The therapy trail from lab to patient is not for the faint-hearted
2nd November 2023
Identity parade
Across an intricate supply chain accuate labelling has never been more vital
1st November 2023
Human beginning
Applying artificial intelligence to your clinical resourcing and talent acquisition strategy won't signal the end of humankind
6th October 2023
Getting the brand back together
Harnessing the power of an established identity is essential when navigating uncertainty across pharma
4th October 2023
ABPI blog
MHRA’s new 'International Recognition Procedure' – how does it shape up?
22nd September 2023
With great power comes great responsibility
AI in drug discovery has arrived but how can pharma use it as a force for good?
19th September 2023
